Aspen Joins World Thrombosis Day Campaign
Company Joins Movement as Global Contributor to Raise Awareness of Thrombosis as an Urgent Health Problem Worldwide
September 01, 2016 – Aspen, a leading global player in specialty and generic pharmaceuticals with an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life, today announced its support as an official Global Contributor for World Thrombosis Day, a campaign of the International Society on Thrombosis and Haemostasis (ISTH).
A year-long campaign recognised on 13 October, World Thrombosis Day focuses attention on the often overlooked and misunderstood condition of thrombosis. With thousands of educational events in more than 80 countries around the world, World Thrombosis Day and its 500 partners place a global spotlight on thrombosis as an urgent and growing health problem. Together, the collaboration aims to reduce death and disability caused by thrombosis.
“With one in four people worldwide dying of conditions caused by thrombosis, Aspen is energised and proud to pledge its support to the World Thrombosis Day campaign,” said David Pedelabat-Lartigau, Head of Marketing Global, Aspen. “The campaign’s commitment to raising global awareness of thrombosis, specifically venous thromboembolism and stroke, as well as improving patient outcomes, closely aligns with Aspen’s strong commitment to healthcare and patients. We are excited to partner with the campaign to increase public and health professionals’ awareness of potentially deadly blood clots in the leg and lungs, the risk factors, signs, symptoms and the importance of prevention.”
In its third year, the World Thrombosis Day campaign seeks to ensure citizens of the world “Know Thrombosis” and understand the steps to take to “Keep Life Flowing.” Based on a global survey conducted in nine countries among men and women, too few people know about thrombosis, specifically blood clots in the leg (deep vein thrombosis) and lungs (pulmonary embolism) and their life-threatening consequences. The campaign urges people to: 1) Know the risk factors; 2) Know the signs and symptoms; 3) Be proactive and talk to a health care professional about risk and prevention of blood clots, especially if admitted to the hospital or having surgery.
“We are honored to welcome Aspen Pharma as an official Global Contributor of the campaign,” said Dr. Gary Raskob, dean of the College of Public Health, University of Oklahoma Health Sciences Center, and chairman of the World Thrombosis Day Steering Committee. “We are excited to work together to increase awareness at all levels – personal, health care systems, providers, and policy makers – to collectively encourage prevention and to continue addressing thrombosis as an urgent and growing health problem.”
For more information about World Thrombosis Day, visit www.worldthrombosisday.org. To learn more about Aspen, visit www.aspenpharma.com.
Aspen is a leading global player in specialty and generic pharmaceuticals with an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. Aspen continues to increase the number of lives benefitting from its products, reaching more than 150 countries.
Aspen has a strong presence in both emerging and developed countries. Its emerging market footprint includes Sub-Saharan Africa (where it is the largest pharmaceutical company), Latin America, South East Asia, Eastern Europe and the Commonwealth of Independent States, comprising Russia and the former Soviet Republics. From a developed world perspective Aspen is one of the leading pharmaceutical companies in Australia and has a growing presence in other developed countries, most notably in Western Europe.
Aspen operates with an established business presence in approximately 50 countries spanning 6 continents and employs more than 10,000 people. The Group operates 26 manufacturing facilities across 18 sites. Aspen holds international manufacturing approvals from some of the most stringent global regulatory agencies including the FDA, TGA and EMA. Aspen’s manufacturing capabilities are scalable to demand and cover a wide variety of product-types including oral solid dose, liquids, semi-solids, steriles, biologicals, APIs and INs.
Aspen, with a market capitalisation of approximately $10 billion, is the largest pharmaceutical company listed on the JSE Limited (share code: APN) and ranks amongst the top 20 listed companies on this exchange.
About World Thrombosis Day
Launched in 2014 and held annually on 13 October, World Thrombosis Day (WTD) aims to increase public, healthcare professional and health care systems’ awareness of thrombosis and, ultimately, to reduce deaths and disabilities from thromboembolic disease through a greater awareness of its causes, risk factors, signs and symptoms, and evidence-based prevention and treatment. WTD’s mission supports the World Health Assembly’s global target of reducing premature deaths by non-communicable disease by 25 percent by 2025, as well as the WHO global action plan for the prevention and control of non-communicable diseases in the 2013-2020 timeframe. Visit www.worldthrombosisday.org for more information.
About the ISTH
Founded in 1969, the ISTH is the leading worldwide not-for-profit organisation dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. ISTH is an international professional membership organization with 4,000 clinicians, researchers and educators working together to improve the lives of patients in more than 93 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs such as its Core Curriculum, research activities; meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Visit ISTH online at www.isth.org.
Marketing Manager Europe CIS
+49 899 308 380 58
World Thrombosis Day
Barbara Krolak, Relationship and Campaign Specialist
International Society on Thrombosis and Haemostasis
+1 919 929 3807